Locally advanced cervical cancer: Preliminary results of the prospective randomized study [PDF]
Archive of Oncology, 2003 Background: The aim of this study is to show preliminary results of the randomized study that has been conducted among patients with advanced cervical cancer managed by loco-regional radiotherapy alone or combined treatment (radiotherapy with ...
Stanković Vesna V. +5 more
doaj +1 more source
Brazilian Journal of Oncology, 2020 Objective: Systemic treatment of advanced pancreatic adenocarcinoma has resulted in increased survival of patients, but real-life data are scarce, particularly in developing countries.
Paloma Porto Amorim +3 more
doaj +1 more source
The role of radiotherapy in combined treatment for locally advanced breast cancer with ipsilateral supraclavicular metastases [PDF]
Archive of Oncology, 2003 Background: Locally advanced breast cancer (LABC) includes a heterogeneous group of breast neoplasms classified from stage IIB, IIIA to IIIB. LABC with ipsilateral supraclavicular adenopathy without evidence of distant disease is included in the stage IV
Mladenović Jasmina +6 more
doaj +1 more source
Scalp cooling to prevent chemotherapy-induced alopecia, [PDF]
Anais Brasileiros de Dermatologia, 2020 Chemotherapy-induced alopecia causes an important impact on cancer patients and its risk of persistence is currently a considerable issue in cancer survivors.
Giselle de Barros Silva +3 more
doaj +1 more source
Efficacy and safety of bevacizumab in combination with irinotecan and capecitabine in first-line treatment of metastatic colorectal carcer [PDF]
Vojnosanitetski Pregled, 2017 Background/Aim. The efficacy and safety of bevacizumab (BEV) in combination with capecitabin and irinotecan in first-line therapy for patients with metastatic colorectal cancer (mCRC) were studied. In order to improve safety and efficacy of chemotherapy,
Jungić Saša +4 more
doaj +1 more source
Health care during administration of combined docetaxel-Mitomycin C-Vinblastin therapy in treatment of metastatic breast cancer patients [PDF]
Archive of Oncology, 2003 Background: New chemotherapy combinations are extensively investigated in metastatic breast cancer, especially in anthracycline resistant patients. However, the higher the treatment efficacy, usually the greater therapy side effects are reported.
Mitrović Jasmina +2 more
doaj +1 more source
Spider venom administration impairs glioblastoma growth and modulates immune response in a non-clinical model. [PDF]
, 2020 Molecules from animal venoms are promising candidates for the development of new drugs. Previous in vitro studies have shown that the venom of the spider Phoneutria nigriventer (PnV) is a potential source of antineoplastic components with activity in ...
Barreto, Natália +12 more
core +1 more source
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma [PDF]
, 2003 BACKGROUND: We wished to evaluate the clinical response following ATP-Tumor Chemosensitivity Assay (ATP-TCA) directed salvage chemotherapy in a series of UK patients with advanced ovarian cancer. The results are compared with that of a similar assay used
A du Bois +59 more
core +4 more sources
BLEOMYCIN-INDUCED FLAGELLATE DERMATITIS: A CASE REPORT
Cogitare Enfermagem, 2015 Flagellate Dermatitis consists of cutaneous hyperpigmentation with a flagellate appearance, one specific cause of which is bleomycin. Bleomycin is a chemotherapy agent used in the treatment of different neoplasias.
Walfrido Bispo Junior +3 more
doaj +1 more source
Clinical Hematology International, 2020 Dose-adjusted rituximab, etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin (DA.R-EPOCH) is used for upfront treatment of high-risk diffuse large B cell lymphoma (DLBCL).
Bhagirathbhai Dholaria +7 more
doaj +1 more source